Effect of tricuspid regurgitation and right ventricular dysfunction on long-term mortality in patients undergoing cardiac devices implantation: >10-year follow-up study.

The long-term effect of tricuspid regurgitation (TR) after device implantation on long-term mortality remains unknown. In the present study, we sought to examine whether patients undergoing an implantable cardiac device procedure (pacemaker, cardiac defibrillator or cardiac resynchronisation therapy) have an increased risk of TR and to determine the effect of this on long-term survival. A total of 304 patients who underwent device implant and had pre- and post-implant transthoracic echocardiogram were included in the analysis. All-cause mortality was the study endpoint over a follow-up period of median 11.6 years. New ≥ moderate tricuspid regurgitation post-device implantation developed in 66/304 (21.7%) patients. New right ventricular dysfunction post-device implantation occurred in 59/304 (19.4%) patients. Independent predictors of new RV dysfunction were ischaemic heart disease (OR 4.23, 95% CI 1.58 – 11.33, p = 0.004), left ventricular impairment (OR 2.74, 95% CI 5.41 – 30.00, p < 0.0001) and new ≥ moderate TR (OR 7.72, 95% CI 3.27 – 18.23, p < 0.001). Independent predictors of mortality were new ≥ moderate TR [HR: 3.14 (95% CI 1.29 – 7.63) p = 0.01] and new RV impairment [HR: 2.82 (95% CI 1.33 – 5.98) p = 0.01. Worsening TR and RV dysfunction post-device implantation is common. New post-implant ≥ moderate TR is associated with increased risk of new RV impairment and poor long term (>10 years) survival. • Worsening TR and RV dysfunction post-device implantation is common. • Post-implant ≥ moderate TR is associated with increased risk of new RV impairment. • Post-implant ≥ moderate TR is associated with poor long-term survival. [ABSTRACT FROM AUTHOR]